Croatia vs Portugal: Cause of death, by non-communicable diseases, ages 15-59
Croatia
72.8%
in 2021
Portugal
72.8%
in 2021
Croatia rank
32nd
Portugal rank
31st
Cause of death, by non-communicable diseases, ages 15-59 over time
- Croatia
- Portugal
How they compare
Portugal currently reports 72.8% against 72.8% in Croatia, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Croatia ahead.
Croatia ranks 32nd and Portugal ranks 31st of 185 countries.
Croatia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Croatia | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 77.8% | 70.8% | 7.1% | Croatia |
| 2010s | 82.8% | 78.2% | 4.5% | Croatia |
| 2020s | 75.4% | 73.3% | 2.1% | Croatia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Croatia or Portugal?
- Portugal, at 72.8% against 72.8% in Croatia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Croatia and Portugal?
- 0.0%, with Portugal ahead.
- How many years of comparable data are there for Croatia and Portugal?
- 6 years are reported by both, from 2000 to 2021.
- How do Croatia and Portugal rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Croatia ranks 32nd and Portugal ranks 31st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.